Fulgent Genetics (FLGT) Deferred Taxes (2016 - 2026)

Fulgent Genetics has disclosed Deferred Taxes across 9 years of filings, most recently posting -$1.1 million for Q1 2026.

• Deferred Taxes for Q1 2026 came in at -$1.1 million, down 742.11% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.2 million (up 33.54% YoY), and the FY2025 annual result was -$1.2 million, up 67.51% from the prior year.
• Deferred Taxes came in at -$1.1 million for Q1 2026 at Fulgent Genetics, down from -$104000.0 in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of $19.4 million in Q3 2023 to a low of -$5.5 million in Q1 2022.
• The 5-year median for Deferred Taxes is -$557000.0 (2024), against an average of -$169647.1.
• Across the five-year window, Deferred Taxes jumped 616.52% in 2023 and plunged 742.11% in 2026, its largest moves.
• Fulgent Genetics' Deferred Taxes stood at -$3.3 million in 2022, then surged by 115.0% to $502000.0 in 2023, then slumped by 172.51% to -$364000.0 in 2024, then jumped by 71.43% to -$104000.0 in 2025, then tumbled by 976.92% to -$1.1 million in 2026.
• The last three Deferred Taxes figures came in at -$1.1 million (Q1 2026), -$104000.0 (Q4 2025), and -$864000.0 (Q3 2025), per Business Quant data.